In prostate cancer the over-expression of B-cell leukemia 3 (Bcl3) protein is correlated with the expression of Id1 and Id2, which is in turn accompanied with resistance to pro-apoptotic drugs [118]. This evidence concerns the gene ID2 and prostate carcinoma.